![]() |
|
|
Vol. 285, Issue 1, 105-109, April 1998
Department of Pharmacology, Dalhousie University, Halifax, Nova
Scotia, Canada
The role of protein kinase C (PKC) in the
N-methyl-D-aspartate (NMDA)-evoked release of adenosine
(ADO) and [3H]norepinephrine (NE) from slices of rat
parietal cortex was studied. In the absence of Mg++, the
PKC activator phorbol 12-myristate 13-acetate (1 µM, PMA) did not
release either ADO or [3H]NE, but it potentiated the
release of ADO evoked by 20 µM NMDA and the release of
[3H]NE evoked by 100 µM NMDA. These potentiating
effects of PMA on the NMDA-evoked release of ADO and
[3H]NE were reversed by the PKC inhibitor GF109,203X (1 µM). GF109,203X by itself had no effect on the NMDA-evoked release of
either ADO or [3H]NE. In the presence of
Mg++, PMA did not permit the NMDA-evoked release of
[3H]NE to occur. These results indicate that PKC does not
play an essential role in the NMDA-evoked release of either ADO or NE. However, activation of PKC potentiates the release of ADO and NE evoked
by submaximal concentrations of NMDA. Activation of PKC will have the
effect of increasing the inhibitory threshold provided by released ADO
when only a few NMDA receptors are activated and will promote and
accelerate excitatory responses when most of the available NMDA
receptors become activated.